Daily BriefsECM

Daily Brief ECM: Harita Nickel IPO – The Negatives – Reliant on JVs and with Lygend Group. Market Is About to Shift and more

In today’s briefing:

  • Harita Nickel IPO – The Negatives – Reliant on JVs and with Lygend Group. Market Is About to Shift
  • DPC Dash IPO – Might Be Worth a Small Slice
  • Trial Holdings IPO: Valuation Insights
  • Blue Jet Healthcare Pre-IPO – Marquee Clients but Inconsistent Growth and Margins
  • Harita Nickel IPO: The Bull Case
  • DPC Dash IPO Valuation: Looks Expensive Cf. Yum China & Dominos Master Franchisees in Other Regions
  • Kelsian Group Placement – Yet Another Acquisition to Add to Its Arsenal
  • ZKH IPO: Neither Good nor Bad

Harita Nickel IPO – The Negatives – Reliant on JVs and with Lygend Group. Market Is About to Shift

By Clarence Chu

  • PT Trimegah Bangun Persada Tbk (Harita Nickel) (2230010D IJ) is looking to raise about US$650m in its Indonesian IPO.
  • PT Trimegah Bangun Persada Tbk (Harita Nickel, HN) is a vertically integrated pure-play nickel company operating on Obi Island, Indonesia.
  • In this note, we will talk about the not so positive aspects of the deal.

DPC Dash IPO – Might Be Worth a Small Slice

By Sumeet Singh

  • DPC Dash (1405 HK) is now looking to raise up to US$90m, after having shelved its last attempt to raise around US$75m in its Hong Kong IPO in December.
  • The company is the exclusive master franchisee for Domino’s Pizza in China, HK and Macau. DPC operated 604 stores across 17 cities, as of Feb 2023.
  • In this note, we run the deal through our ECM framework and talk about valuations.

Trial Holdings IPO: Valuation Insights

By Arun George


Blue Jet Healthcare Pre-IPO – Marquee Clients but Inconsistent Growth and Margins

By Sumeet Singh

  • Blue Jet Healthcare Ltd (BJHC IN)  is looking to raise about US$300m in its upcoming India IPO.
  • Blue Jet Healthcare (BJH) is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted toward innovator pharmaceutical companies and multinational generic pharmaceutical companies. 
  • In this note, we look at the company’s past performance.

Harita Nickel IPO: The Bull Case

By Arun George

  • PT Trimegah Bangun Persada Tbk (Harita Nickel) (2230010D IJ), an Indonesian nickel play, has launched an IDX IPO to raise US$650 million. Book building ends on 21 March.
  • Harita is expected to become Indonesia’s largest pure nickel producer based on volume expectations of Harita’s nickel mining production in 2022.
  • The key elements of the bull case rest on good underlying revenue growth, near-term capacity expansion, high profitability, capex nearing the peak and manageable leverage.

DPC Dash IPO Valuation: Looks Expensive Cf. Yum China & Dominos Master Franchisees in Other Regions

By Oshadhi Kumarasiri

  • The exclusive master franchisee of Domino’s Pizza in mainland China, Hong Kong and Macau, DPC Dash’s IPO opened for subscriptions today at a price range of HK$ 46.0-55.0 per share.
  • The IPO valuation is not particularly enticing to lure us as we don’t think it’s at a sufficient discount to Yum China Holdings Inc (9987 HK)’s multiples.
  • DPC Dash (1405 HK) is also relatively more expensive than Domino’s Pizza (DPZ US) master franchisees in other regions.

Kelsian Group Placement – Yet Another Acquisition to Add to Its Arsenal

By Ethan Aw

  • Kelsian Group (KLS AU) aims to raise around US$90m (A$135m) via an institutional placement. Together with the placement, the company will also undertake a US$95m (A$143m) non-renounceable entitlement offer. 
  • The issuance of new shares will be a large one for the firm to digest, representing 150.6 days of three month ADV and 20.3% of current mcap. 
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

ZKH IPO: Neither Good nor Bad

By Shifara Samsudeen, ACMA, CGMA

  • ZKH Group (ZKH US) is a leading MRO procurement service platform in China offering digital and fulfilment solutions for participants in the industry value chain.
  • The company has filed for an IPO to list its shares in the US and plans to raise about US$200-300m through the IPO.
  • Having analyzed the limited information available, we are indifferent on ZKH’s operating performance and would only recommend if shares are priced attractively

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars